|
1
|
Chen Y, Kang Y, Hong L and Yao H:
Hypoglycemia caused by co-secretion of insulin from lung tumor and
cardia cancer: First case report. Sao Paulo Med J. Nov
17–2017.(Epub ahead of print). View Article : Google Scholar
|
|
2
|
Guo W, Lv P, Liu S, Xu F, Guo Y, Shen S,
Liang J, Kuang G and Dong Z: Aberrant methylation-mediated
downregulation of long noncoding RNA C5orf66-AS1 promotes the
development of gastric cardia adenocarcinoma. Mol Carcinog. Mar
22–2018.(Epub ahead of print]). View
Article : Google Scholar
|
|
3
|
Barra WF, Moreira FC, Cruz Pereira AM,
Khayat AS, Calcagno DQ, Dos Santos Carneiro NP, Junior Mascarenhas
RW, Araújo Thomaz TM, Ishak G, Demachki S, et al: GEJ cancers:
Gastric or esophageal tumors? searching for the answer according to
molecular identity. Oncotarget. 8:104286–104294. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Binh TT, Tuan VP, Dung HDQ, Tung PH, Tri
TD, Thuan NPM, Khien VV, Hoan PQ, Suzuki R, Uchida T, et al:
Advanced non-cardia gastric cancer and Helicobacter pylori
infection in Vietnam. Gut Pathog. 9:462017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Roviello F, Polom K, D'Ignazio A, Pascale
V and Marrelli D: K-RAS mutation in gastric cancer and its link
with microsatellite instability status. Eur J Cancer. 92 Suppl
2:S62018. View Article : Google Scholar
|
|
6
|
Sekita-Hatakeyama Y, Nishikawa T, Takeuchi
M, Morita K, Takeda M, Hatakeyama K, Nakai T, Uchiyama T, Itami H,
Fujii T, et al: K-ras mutation analysis of residual liquid-based
cytology specimens from endoscopic ultrasound-guided fine needle
aspiration improves cell block diagnosis of pancreatic ductal
adenocarcinoma. PLoS One. 13:e01936922018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lin YJ and Haigis KM: Brother's keeper:
Wild-type mutant K-ras dimers limit oncogenesis. Cell. 172:645–647.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jimbo K, Yokoyama K, Ogawa M, Hirano M,
Ochi K, Kobayashi M, Yusa N, Shimizu E, Kawamata T, Yasui H, et al:
Autologous peripheral blood stem cell transplantation for
double-refractory myeloma with K-RAS and N-RAS mutations. Rinsho
Ketsueki. 58:2380–2385. 2017.(In Japanese). PubMed/NCBI
|
|
9
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Siddiqui I, Erreni M, Kamal MA, Porta C,
Marchesi F, Pesce S, Pasqualini F, Schiarea S, Chiabrando C,
Mantovani A, et al: Differential role of Interleukin-1 and
Interleukin-6 in K-Ras-driven pancreatic carcinoma undergoing
mesenchymal transition. OncoImmunology. 7:e13884852017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang X, Wang J, Chen F, Zhong Z and Qi L:
Detection of K-ras gene mutations in feces by magnetic nanoprobe in
patients with pancreatic cancer: A preliminary study. Exp Ther Med.
15:527–531. 2018.PubMed/NCBI
|
|
12
|
Zhou Y and Hancock JF: A novel
prenyl-polybasic domain code determines lipid-binding specificity
of the K-Ras membrane anchor. Small GTPases. 15:1–5. 2018.
View Article : Google Scholar
|
|
13
|
Son BK, Kim DH, Min KW, Kim EK and Kwon
MJ: Smad4/Fascin index is highly prognostic in patients with
diffuse type EBV-associated gastric cancer. Pathol Res Pract.
214:475–481. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Koçer NE and Kayaselçuk F: Is availability
of anti-EGFR therapy for the colorectal adenocarcinomas showing
fascin expression limited? Target Oncol. 9:171–175. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang MT, Holderfield M, Galeas J,
Delrosario R, To MD, Balmain A and McCormick F: K-Ras promotes
tumorigenicity through suppression of non-canonical Wnt signaling.
Cell. 163:1237–1251. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xu W, Wang Z, Zhang W, Qian K, Li H, Kong
D, Li Y and Tang Y: Mutated K-ras activates CDK8 to stimulate the
epithelial-to-mesenchymal transition in pancreatic cancer in part
via the Wnt/β-catenin signaling pathway. Cancer Lett. 356:(2 Pt B).
613–627. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Stewart CJ and Crook ML: Fascin expression
in undifferentiated and dedifferentiated endometrial carcinoma. Hum
Pathol. 46:1514–1520. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee LY, Chen YJ, Lu YC, Liao CT, Chen IH,
Chang JT, Huang YC, Chen WH, Huang CC, Tsai CY, et al: Fascin is a
circulating tumor marker for head and neck cancer as determined by
a proteomic analysis of interstitial fluid from the tumor
microenvironment. Clin Chem Lab Med. 53:1631–1641. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhao W, Gao J, Wu J, Liu QH, Wang ZG, Li
HL and Xing LH: Expression of Fascin-1 on human lung cancer and
paracarcinoma tissue and its relation to clinicopathological
characteristics in patients with lung cancer. Onco Targets Ther.
8:2571–2576. 2015.PubMed/NCBI
|
|
20
|
Abrams JA, Gonsalves L and Neugut AI:
Diverging trends in the incidence of reflux-related and
Helicobacter pylori-related gastric cardia cancer. J Clin
Gastroenterol. 47:322–327. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Omran OM and Al Sheeha M: Cytoskeletal
focal adhesion proteins fascin-1 and paxillin are predictors of
malignant progression and poor prognosis in human breast cancer. J
Environ Pathol Toxicol Oncol. 34:201–212. 2015. View Article : Google Scholar : PubMed/NCBI
|
